Your browser doesn't support javascript.
loading
Independent and joint effect of type 2 diabetes and gastric and hepatobiliary diseases on risk of pancreatic cancer risk: 10-year follow-up of population-based cohort.
Lin, C-C; Chiang, J-H; Li, C-I; Hsieh, T-F; Liu, C-S; Lin, W-Y; Lee, Y-D; Li, T-C.
Afiliación
  • Lin CC; 1] Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan [2] School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan [3] Department of Medical Research, China Medical University Hospital, Taichung, Taiwan.
  • Chiang JH; 1] Graduate Institute of Biostatistics, College of Management, China Medical University, Taichung, Taiwan [2] Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan [3] Research Center for Chinese Medicine and Acupuncture, China Medical University, Taichung, Taiwan.
  • Li CI; 1] School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan [2] Department of Medical Research, China Medical University Hospital, Taichung, Taiwan.
  • Hsieh TF; 1] Division of Urology, Department of Surgery, Buddhist Tzu Chi General Hospital, Taichung Branch, Taichung, Taiwan [2] School of Medicine, Buddhist Tzu Chi University, Hualien, Taiwan [3] Graduate Institute of Clinical Medical Science, College of Medicine, China Medical University, Taichung, Taiwan
  • Liu CS; 1] Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan [2] School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan [3] Department of Medical Research, China Medical University Hospital, Taichung, Taiwan.
  • Lin WY; 1] Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan [2] School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan.
  • Lee YD; 1] Department of Psychiatry, Medical College, National Cheng-Kung University, Tainan, Taiwan [2] Global Development and Medical Affairs, Bristol-Myers Squibb (Taiwan) Ltd, Taipei, Taiwan.
  • Li TC; 1] Graduate Institute of Biostatistics, College of Management, China Medical University, Taichung, Taiwan [2] Research Center for Chinese Medicine and Acupuncture, China Medical University, Taichung, Taiwan [3] Department of Healthcare Administration, College of Medical and Health Science, Asia Univ
Br J Cancer ; 111(11): 2180-6, 2014 Nov 25.
Article en En | MEDLINE | ID: mdl-25275365
ABSTRACT

BACKGROUND:

Type 2 diabetes mellitus, gastric and hepatobiliary comorbidities, and cancer share common risk factors for example, tobacco, obesity, physical inactivity, high calorie intake, and metabolic disorders. Prior studies find type 2 diabetes and gastric and hepatobiliary comorbidities heightening risk of pancreatic cancer. Yet joint association of type 2 diabetes mellitus and gastric and hepatobiliary comorbidities on pancreatic cancer risk has not been assessed.

METHODS:

This study rates independent/joint effects of type 2 diabetes as well as gastric and hepatobiliary comorbidity on pancreatic cancer risk for a retrospective population-based cohort of 166,850 type 2 diabetics identified in 1997-1998 and followed for 10-11 years, comparing their cancer incidence with that of 166,850 non-diabetics matched for age, gender, and locale. Time-dependent Cox's proportional hazards model evaluted joint association of type 2 diabetes and chronic conditions on pancreatic cancer risk.

RESULTS:

A total of 1178 subjects were newly diagnosed with pancreatic cancer during follow-up, with incidence rates of 0.49 per 1000 person-years in type 2 diabetes and 0.26 per 1000 person-years in the non-diabetics. We observed greater magnitude of hazard ratios (HRs) of pancreatic cancer for patients with type 2 diabetes along with acute alcoholic hepatitis, acute pancreatitis, cholecystitis, and gastric ulcer compared with patients without type 2 diabetes or counterpart comorbidity (HR 1.36, 95% confidence interval (CI) 1.19-1.56; 1.74, 1.23-2.45; 9.18, 7.44-11.33; and 2.31, 1.98-2.70, respectively). Main effects of type 2 diabetes were all statistically with narrow 95% CI and remained similar across risk stratification with various comorbidities range 1.59-1.80.

CONCLUSIONS:

Our study demonstrates that pre-existing type 2 diabetes, acute alcoholic hepatitis, acute pancreatitis, cholecystitis, and gastric ulcer independently or jointly predict subsequent pancreatic cancer risk. Clinicians must recognise burden of these gastric and hepatobiliary comorbidities and keep clinically vigilant for their diagnosis.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Gastropatías / Diabetes Mellitus Tipo 2 / Hepatopatías Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2014 Tipo del documento: Article País de afiliación: Taiwán
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Gastropatías / Diabetes Mellitus Tipo 2 / Hepatopatías Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2014 Tipo del documento: Article País de afiliación: Taiwán